Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michelle Swanson

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
Trends in Immunology|April 3, 2007
Epstein-Barr virus latent membrane protein 2A and autoimmunityMichelle Swanson-Mungerson, Richard Longnecker
Journal of Virology|July 1, 2006
Epstein-Barr virus LMP2A enhances B-cell responses in vivo and in vitroMichelle Swanson-Mungerson, Rebecca Bultema, Richard Longnecker
The Journal of General Virology|May 21, 2010
Epstein-Barr virus LMP2A imposes sensitivity to apoptosisMichelle Swanson-Mungerson, Rebecca Bultema, Richard Longnecker
Immunity, Inflammation and Disease|October 27, 2022
The impact of Epstein-Barr virus latent membrane protein 2A on the production of B cell activating factor of the tumor necrosis factor family (BAFF), APRIL and their receptorsKevin Madayag, Ryan Incrocci, Michelle Swanson-Mungerson
The Journal of General Virology|January 11, 2013
Epstein-Barr virus LMP2A increases IL-10 production in mitogen-stimulated primary B-cells and B-cell lymphomasRyan Incrocci, Molly McCormack, Michelle Swanson-Mungerson
Cell Cycle (Georgetown, Tex.)|February 18, 2010
Epstein-Barr virus in Burkitt's lymphoma: a role for latent membrane protein 2AKathryn T Bieging, Michelle Swanson-Mungerson, Alexandra C Amick, et al.
Lippincott'S Case Management : Managing the Process of Patient Care|December 1, 2005
Case management evolution: from basic to advanced practice roleMarietta P Stanton, Michelle Swanson, Roy Ann Sherrod, et al.
Drug Discovery Today|June 24, 2020
Discovering small-molecule therapeutics against SARS-CoV-2Vaibhav Tiwari, Jacob C Beer, Nehru Viji Sankaranarayanan, et al.
International Journal of Molecular Sciences|April 13, 2024
Epstein-Barr Virus Latent Membrane Protein 2A (LMP2A) Enhances ATP Production in B Cell Tumors through mTOR and HIF-1αRyan Incrocci, Rosalinda Monroy Del Toro, Grace Devitt, et al.
Journal of Medical Virology|January 5, 2019
Epstein-Barr virus LMP2A utilizes Syk and PI3K to activate NF-κB in B-cell lymphomas to increase MIP-1α productionRyan Incrocci, Jason McAloon, Michael Montesano, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Trends in Immunology|April 3, 2007
Epstein-Barr virus latent membrane protein 2A and autoimmunityMichelle Swanson-Mungerson, Richard Longnecker
Journal of Virology|July 1, 2006
Epstein-Barr virus LMP2A enhances B-cell responses in vivo and in vitroMichelle Swanson-Mungerson, Rebecca Bultema, Richard Longnecker
The Journal of General Virology|May 21, 2010
Epstein-Barr virus LMP2A imposes sensitivity to apoptosisMichelle Swanson-Mungerson, Rebecca Bultema, Richard Longnecker
Immunity, Inflammation and Disease|October 27, 2022
The impact of Epstein-Barr virus latent membrane protein 2A on the production of B cell activating factor of the tumor necrosis factor family (BAFF), APRIL and their receptorsKevin Madayag, Ryan Incrocci, Michelle Swanson-Mungerson
The Journal of General Virology|January 11, 2013
Epstein-Barr virus LMP2A increases IL-10 production in mitogen-stimulated primary B-cells and B-cell lymphomasRyan Incrocci, Molly McCormack, Michelle Swanson-Mungerson
Cell Cycle (Georgetown, Tex.)|February 18, 2010
Epstein-Barr virus in Burkitt's lymphoma: a role for latent membrane protein 2AKathryn T Bieging, Michelle Swanson-Mungerson, Alexandra C Amick, et al.
Lippincott'S Case Management : Managing the Process of Patient Care|December 1, 2005
Case management evolution: from basic to advanced practice roleMarietta P Stanton, Michelle Swanson, Roy Ann Sherrod, et al.
Drug Discovery Today|June 24, 2020
Discovering small-molecule therapeutics against SARS-CoV-2Vaibhav Tiwari, Jacob C Beer, Nehru Viji Sankaranarayanan, et al.
International Journal of Molecular Sciences|April 13, 2024
Epstein-Barr Virus Latent Membrane Protein 2A (LMP2A) Enhances ATP Production in B Cell Tumors through mTOR and HIF-1αRyan Incrocci, Rosalinda Monroy Del Toro, Grace Devitt, et al.
Journal of Medical Virology|January 5, 2019
Epstein-Barr virus LMP2A utilizes Syk and PI3K to activate NF-κB in B-cell lymphomas to increase MIP-1α productionRyan Incrocci, Jason McAloon, Michael Montesano, et al.
Pageof 3